Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Urology ; 60(4): 617-22, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12385921

RESUMEN

OBJECTIVES: To examine the nuclear chromatin characteristics of epithelial cells, looking for an SPHB-mediated effect on nuclear DNA structure and organization. Saw palmetto herbal blend (SPHB) causes contraction of prostate epithelial cells and suppression of tissue dihydrotestosterone levels in men with symptomatic benign prostatic hyperplasia, but a fundamental mechanism remains unknown. METHODS: A 6-month randomized trial, comparing prostatic tissue of men treated with SPHB (n = 20) or placebo (n = 20), was performed. At baseline, the two groups were similar in age (65 versus 64 years), symptoms (International Prostate Symptom Score 18 versus 17), uroflow (maximal urinary flow rate 10 versus 11 mL/s), prostate volume (59 versus 58 cm(3)), prostate-specific antigen (4.2 versus 2.7 ng/mL), and percentage of epithelium (17% versus 16%). Prostatic tissue was obtained by sextant biopsy before and after treatment. Five-micron sections were Feulgen stained and quantitatively analyzed using the AutoCyte QUIC-DNA imaging system. Images were captured from 200 randomly selected epithelial cell nuclei, and 60 nuclear morphometric descriptors (NMDs) (eg, size, shape, DNA content, and textural features) were determined for each nucleus. Logistic regression analysis was used to assess the differences in the variances of the NMDs between the treated and untreated prostate epithelial cells. RESULTS: At baseline, the SPHB and placebo groups had similar NMD values. After 6 months of placebo, no significant change from baseline was found in the NMDs. However, after 6 months of SPHB, 25 of the 60 NMDs were significantly different compared with baseline, and a multivariate model for predicting treatment effect using 4 of the 25 was created (P <0.001). The multivariate model had an area under the receiver operating characteristic curve of 94% and an accuracy of 85%. CONCLUSIONS: Six months of SPHB treatment appears to alter the DNA chromatin structure and organization in prostate epithelial cells. Thus, a possible molecular basis for tissue changes and therapeutic effect of the compound is suggested.


Asunto(s)
Antagonistas de Andrógenos/uso terapéutico , Núcleo Celular/química , ADN/análisis , Extractos Vegetales/uso terapéutico , Próstata/efectos de los fármacos , Hiperplasia Prostática/tratamiento farmacológico , Anciano , Antagonistas de Andrógenos/farmacología , Núcleo Celular/efectos de los fármacos , Cromatina/química , Cromatina/efectos de los fármacos , ADN/metabolismo , Dihidrotestosterona/metabolismo , Método Doble Ciego , Células Epiteliales/química , Células Epiteliales/efectos de los fármacos , Células Epiteliales/ultraestructura , Humanos , Cariometría/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Placebos , Extractos Vegetales/farmacología , Próstata/química , Próstata/patología , Hiperplasia Prostática/metabolismo , Hiperplasia Prostática/patología , Curva ROC , Serenoa , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA